L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), sold 20,805 shares at $20.56 ($428K) on 2017-02-22, disclosed to the SEC on 2017-02-24.
Open-market sale of $428k RVNC by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.56 | 9,768 | $201K | 46.9% |
| 2 | $20.56 | 9,768 | $201K | 46.9% |
| 3 | $20.70 | 1,269 | $26K | 6.1% |
| Total | $20.57 avg | 20,805 | $428K | 100% |
| Filing → |
| RVNC | SELL | 2018-03-16 | $376K | — | Filing → |
| RVNC | SELL | 2018-03-09 | $1.7M | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |